The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA
Authors:
- 22 November 2011
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 24 (6) , 1088-1106
Abstract
Summary: Studies examining intratumor heterogeneity have indicated that several cancer types, including melanoma, can display phenotypic plasticity, corresponding to their capacity to undergo transient reversible cellular changes. Conceptual models constructed to explain the process of cancer propagation differ in their treatment of intratumor heterogeneity. Recent observations of reversible phenotypic heterogeneity in melanoma have led to the proposal of a novel ‘phenotypic plasticity’ model of cancer propagation. Microphthalmia‐associated transcription factor (MITF), the melanocyte ‘lineage‐specific’ transcription factor, has emerged as one of the central players in melanoma phenotypic plasticity. Here we discuss the conceptual models suggested to explain the relations between MITF and melanoma plasticity, in addition to the complex regulatory roles that MITF plays in melanocytes and melanoma development. Finally, we provide an in‐depth literature survey of microRNAs (miRNAs) involved in MITF activity, melanoma propagation and metastasis, in addition to their potential use as agents of personalized therapy.Keywords
This publication has 244 references indexed in Scilit:
- Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?International Journal of Cancer, 2011
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically OrganizedCancer Cell, 2010
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Networks and pathways in pigmentation, health, and diseaseWIREs Mechanisms of Disease, 2009
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal EvolutionCell, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008